Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional

Study of LJP 394 in Lupus Patients With History of Renal Disease

ClinicalTrials.gov ID: NCT00089804

Public ClinicalTrials.gov record NCT00089804. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 27, 2026, 1:32 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled, Three-Arm, Parallel-Group, Multicenter, Multinational Safety and Efficacy Trial of 300 mg and 900 mg of Abetimus Sodium in Systemic Lupus Erythematosus (SLE) Patients With a History of Renal Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary purpose of this study is to determine whether abetimus sodium is more effective than placebo in delaying time to renal flare in SLE patients with a history of renal disease.

Study identification

NCT ID
NCT00089804
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
La Jolla Pharmaceutical Company
Industry
Enrollment
943 participants

Conditions and interventions

Eligibility (public fields only)

Age range
12 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 2004 (Type not available)
Primary completion
Feb 2009 (Actual)
Completion
Feb 2009 (Actual)
Last update posted
Apr 1, 2009

2004 – 2009

United States locations

U.S. sites
32
U.S. states
17
U.S. cities
31
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35294 —
Wallace Rheumatic Study Center Los Angeles California 90048 —
East Bay Rheumatology Medical Group San Leandro California 94578 —
Private Practice San Mateo California 94401 —
CRIA Research Fort Lauderdale Florida 33334 —
Miami Children's Hospital Miami Florida 33155 —
Emory University School of Medicine, Renal Division Atlanta Georgia 30322 —
Private Practice Augusta Georgia 30909 —
Southeast Regional Research Group Savannah Georgia 31406 —
Intermountain Orthopedics Boise Idaho 83702 —
Rheumatology Associates Chicago Illinois 60612 —
Ochsner Clinic Foundation New Orleans Louisiana 70121 —
SOMARC Trials, LLC Greenbelt Maryland 20770 —
Nephrology Associates, PC Flushing New York 11355 —
North Shore - LIJ Health System Lake Success New York 11042 —
Feinstein Institute for Medical Research Manhasset New York 11030 —
Seligman Center for Advanced Therapeutics, NYU Hospital for Joint Diseases New York New York 10003 —
AAIR Research Center Rochester New York 14618 —
Suny Upstate Medical University Syracuse New York 13210 —
Wake Forest University Health Sciences Winston-Salem North Carolina 27157 —
Ohio State University Medical Center Columbus Ohio 43210 —
Healthcare Research Consultants Tulsa Oklahoma 74135 —
Private Practice Camp Hill Pennsylvania 17011 —
Altoona Center for Clinical Research Duncansville Pennsylvania 16635 —
Arthritis Clinic, 371 North Parkway, Suite 400 Jackson Tennessee 38305 —
Amarillo Center for Clinical Research Amarillo Texas 79124 —
Miracle Medical Clinic, 1170 Blalock Road Houston Texas 77055 —
Renal Care Clinic, P.A., 17202 Red Oak Drive Houston Texas 77090 —
Texas Tech University Health Sciences Center Lubbock Texas 79430 —
San Antonio Kidney Disease Center San Antonio Texas 78229 —
Clinical Research & Consulting Center Fairfax Virginia 22030 —
Arthritis Northwest PLLC Spokane Washington 99204 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 169 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00089804, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 1, 2009 · Synced Oct 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00089804 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →